Etrumadenant

Generic Name: Etrumadenant

Brand Names: -

Drug Type: Small Molecule

Chemical Formula: C_₂₃H_₂₂N_₈O

CAS Number: 2239273-34-6

Unique Ingredient Identifier: W0ZE0NT8IF

Associated Conditions: -

Associated Therapies: -

Clinical Trials

Adenosine Antagonists Clinical Trial Pipeline Analysis: 10+

Adenosine antagonists market growth driven by R&D in neurodegenerative diseases, oncology, and cardiovascular disorders. Innovations in formulation and delivery systems enhance efficacy and safety, increasing adoption. Key companies include Arcus Biosciences, Corvus Pharmaceuticals, Portage Biotech, Palobiofarm, iTeos Therapeutics. Promising drugs like Etrumadenant, Ciforadenant, PORT-6, and Inupadenant are in various clinical trial phases.

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

Home Terms & Conditions Privacy Policy